TELEQT Trademark

Trademark Overview

On Thursday, June 7, 2018, a trademark application was filed for TELEQT with the United States Patent and Trademark Office. The USPTO has given the TELEQT trademark a serial number of 87952361. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 18, 2022. This trademark is owned by Wyeth LLC. The TELEQT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
teleqt

General Information

Serial Number87952361
Word MarkTELEQT
Filing DateThursday, June 7, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 18, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 15, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, April 18, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 18, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021SOU EXTENSION 5 GRANTED
Wednesday, July 21, 2021SOU EXTENSION 5 FILED
Tuesday, July 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 21, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, February 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 8, 2021SOU EXTENSION 4 GRANTED
Monday, February 8, 2021SOU EXTENSION 4 FILED
Monday, February 8, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 5, 2020SOU EXTENSION 3 GRANTED
Wednesday, August 5, 2020SOU EXTENSION 3 FILED
Wednesday, August 5, 2020SOU TEAS EXTENSION RECEIVED
Thursday, February 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 3, 2020SOU EXTENSION 2 GRANTED
Monday, February 3, 2020SOU EXTENSION 2 FILED
Monday, February 3, 2020SOU TEAS EXTENSION RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2019SOU EXTENSION 1 GRANTED
Tuesday, August 13, 2019SOU EXTENSION 1 FILED
Tuesday, August 13, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, March 12, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 15, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 11, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, December 9, 2018ASSIGNED TO LIE
Saturday, November 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 16, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 9, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 9, 2018NON-FINAL ACTION E-MAILED
Thursday, August 9, 2018NON-FINAL ACTION WRITTEN
Tuesday, July 31, 2018ASSIGNED TO EXAMINER
Thursday, June 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 11, 2018NEW APPLICATION ENTERED

Related Keywords

teleqt preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological